Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis

    Research output: Contribution to journalArticlepeer-review

    100 Downloads (Pure)

    Abstract

    Cyclic adenosine monophosphate (cAMP) drives genetic polycystic kidney disease (PKD) cystogenesis. Yet within certain PKD families, striking differences in disease severity exist between affected individuals, and genomic and/or environmental modifying factors have been evoked to explain these observations. We hypothesized that PKD cystogenesis is accentuated by an aberrant fetal milieu, specifically by glucocorticoids. The extent and nature of cystogenesis was assessed in explanted wild-type mouse embryonic metanephroi, using 8-Br-cAMP as a chemical to mimic genetic PKD and the glucocorticoid dexamethasone as the environmental modulator. Cysts and glomeruli were quantified by an observer blinded to culture conditions, and tubules were phenotyped using specific markers. Dexamethasone or 8-Br-cAMP applied on their own produced cysts predominantly arising in proximal tubules and descending limbs of loops of Henle. When applied together, however, dexamethasone over a wide concentration range synergized with 8-Br-cAMP to generate a more severe, glomerulocystic, phenotype; we note that prominent glomerular cysts have been reported in autosomal dominant PKD fetal kidneys. Our data support the idea that an adverse antenatal environment exacerbates renal cystogenesis. © 2013 Anders et al.
    Original languageEnglish
    Article numbere57797
    JournalPLoS ONE
    Volume8
    Issue number3
    DOIs
    Publication statusPublished - 12 Mar 2013

    Fingerprint

    Dive into the research topics of 'Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis'. Together they form a unique fingerprint.

    Cite this